TY  - JOUR 
AU  - Instituto Universitario de Biomedicina (IBIOMED)
AU  - Payo‐serafín, Tania
AU  - Méndez Blanco, Carolina
AU  - Fernández Palanca, Paula
AU  - Martínez‐geijo, Jennifer
AU  - Reviejo, María
AU  - Ortiz‐de‐urbina, Juan José
AU  - González-Gallego, Javier
AU  - Marin, Jose J. G
AU  - Mauriz Gutiérrez, José Luis
AU  - San-Miguel, Beatriz
AU  - Bioquimica y Biologia Molecular
DA  - 2024
SN  - 0009-9236
UR  - https://hdl.handle.net/10612/21534
AB  - [EN]Although the treatment landscape has rapidly evolved over the last years, hepatocellular carcinoma (HCC) is one of the most lethal cancers. With recent advances, both immunotherapy and tyrosine kinase inhibitors (TKIs)-based chemotherapy...
LA  - eng
PB  - Wiley
KW  - Fisiología
KW  - Risk
KW  - Tyrosine
TI  - Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
DO  - 10.1002/cpt.3312
T2  - Clinical Pharmacology & Therapeutics
ER  -